The World Health Organization (WHO) recommended the strategies of HIV deprivation since 2016, as they enable people to find out their HIV status according to their comfort. Main trials are still not allowed to sell in Canada. However, a team from the Institute of Investigation of the McGill University Health Center (RI-MUHC) and collaborators of Clinique Médicale l & # 39; Actuel, in Montreal, evaluated a program of self-evaluation of HIV not verified by the application of smartphones and tablets called HIVSmart! at a risky population (men who have sex with humans). The findings of their study – Canada first – were published online this week at the Journal of Medical Inter-Research.
"In order to reach the first 95 of the 95-95-95 goals set by UNAIDS * by 2030, we need to help detect HIV in those who do not know their HIV status. News strategy that has the option to reach The unconcerned, is HIV self-evaluation, "says Dr. Nitika Pant Pai, the main author of this study and researcher of the infectious diseases and immunity in the World Health Program of the RI-MUHC, and associate professor of medicine at McGill University. "HIVSmart! Covers all the breakdowns in the mere process, it works with an approved HIV test, makes it easier to inform and inform the user."
"Promoting screening, HIVSmart! Could help reduce the number of people living with HIV who do not know their status and allow them to start dealing earlier," adds Dr. Réjean Thomas, to study co-author, who is also founder and CEO of Clinique Médicale L & # 39; Actuel. Application as HIVSmart! increases accessibility to tests, especially outside of the main cities, where it is sometimes harder to try for confidential issues. "
HIVSmart! is available for an intelligent software program, which was developed by Dr. Pant Pai and her team at the RI-MUHC for smart phone, tablet or web-based (Android, iPhone and iPad). It informs, interprets and stores data confidently but, most importantly, it connects users to advice or care quickly and encourages the user to stay in care. Initially developed with funding from Grand Challenges Canada, HIVSmart! was evaluated in Montreal thanks to this study funded by the Canadian Institutes of Health Research (CIHR).
HIVSmart! feasibility in Montreal
Between July 2016 and February 2017, researchers carried out a study of 451 men who have sex with men (formerly called MSM) from 18 to 73 years, who attended the Clinique Médicale L & # 39; Actuel to be tested for HIV. They were offered in-home HIV test Test and tablet equipped with the HIVSmart! App. The strategy has proven tests in a non-controlled home environment. Using HIVSmart !, Participants led through the mere process, learning how to make and interpret the test, store results and get care quickly.
"Our study shows that the HIVSmart! Application strategy is feasible, accepted and preferred for an educated, urban MSM population in Montreal," says Dr. Pant Pai. "As a strategy, it is fitting for individuals who prefer to try themselves at their comfort in the comfort of a private space such as their home, office or kiosks. That will be worthwhile!"
HIV self-test for risky populations
In Canada, the HIV epidemic is unimportantly represented in key populations, such as MSM, injexic drug users, indigenous populations and immigrants from HIV-endemic countries. Approximately 18 to 25 percent of Canadian MSM populations do not know about their VI-positive status, and the number can be proportionally higher for IDUs, indigenous populations and immigrants, which underline the need for accessible HIV-mexaprocessing services.
"At the moment we have all the means to eradicate HIV. The HIVSmart! Appo is a way to support patient autonomy," says Dr. Thomas. "Promoting sneezing reduces the number of people who do not know their HIV status, promptly encourage people of HIV-positive people to make their face-load become uninhabitable, and finally eliminate HIV."
Researchers plan to adapt HIVSmart! Self-proving strategy for many attack populations in Canada and worldwide, thus maximizing its public health impact. HIVSmart! A strategy is also proven in South Africa.
UNAIDS Fast-Track Strategy to end AIDS by 2030:
- By 2030, 95% of all people living with HIV will know their HIV status.
- By 2030, 95% of all people with a diagnosed HIV infection will receive sustained antiretroviral therapy.
- By 2030, 95% of all people receiving antiretroviral therapy will have male removal.
Profile of participants
- 84.7% were educated beyond high school;
- 79.5% were hired;
- 52.5% have been proven in the past 6 months.
- 99.3% of the participants who had failed negative and advice after their attempt;
- 0.7% of participants who deserve positive and laboratory-confirmed have been linked to a doctor on the same day;
- 98.8% of participants found the program useful;
- 94% of the participants wanted to recommend it to a friend or companion.
-Research Institute of the MUHC
-McGill University Health Center